Integra LifeSciences Corporation
integralifesciences.comTotal trials
81
Active
5
Phase 3
6
Total enrollment
9,697
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Otitis Media6
- Hydrocephalus5
- Diabetic Foot Ulcer5
- Foot Ulcer, Diabetic4
- Chronic Sinusitis3
- Diabetic Foot Ulcers3
- Sinusitis3
- NPH (Normal Pressure Hydrocephalus)2
Frequently asked questions about Integra LifeSciences Corporation
- How many clinical trials does Integra LifeSciences Corporation have on ClinicalTrials.gov?
- Integra LifeSciences Corporation is listed as the lead sponsor on 81 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Integra LifeSciences Corporation's trials are in Phase 3?
- 6 of Integra LifeSciences Corporation's trials are in Phase 3.
- What therapeutic areas does Integra LifeSciences Corporation focus on?
- Integra LifeSciences Corporation's most-studied conditions on ClinicalTrials.gov are Otitis Media, Hydrocephalus, Diabetic Foot Ulcer, Foot Ulcer, Diabetic, Chronic Sinusitis.